Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerOpenAI sign Language
VIPCreated with Sketch.

Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors.

Y Linda Wu,Grace van Hyfte,Umut Özbek,Marlene Reincke,Anuhya Gampa,Yehia I Mohamed,Naoshi Nishida,Brooke Wietharn,Suneetha Amara,Pei-Chang Lee,Bernhard Scheiner,Lorenz Balcar,Matthias Pinter,Arndt Vogel,Arndt Weinmann,Anwaar Saeed,Anjana Pillai,Lorenza Rimassa,Abdul Rafeh Naqash,Mahvish Muzaffar,Yi-Hsiang Huang,Ahmed O Kaseb,Masatoshi Kudo,David J Pinato,Celina Ang

Frontiers in oncology（2023）

Cited 0|Views27
No score
Abstract
In this real-world population of patients with unresectable HCC treated with immunotherapy, BB use was not associated with OS, PFS or ORR.
More
Translated text
Key words
beta blocker,beta-adrenergic blockade,cancer immunotherapy,hepatocellular carcinoma,immune checkpoint inhibitors
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined